We recently published a list of 12 Best German Stocks to Buy According to Hedge Funds. In this article, we are going to take ...

It comes on the heels of the FDA's top vaccine scientist Peter Marks' exit from the agency, which will be effective April 5.

Vaccine stocks have been under significant pressure in recent days following news that the FDA director who oversaw the ...

Federal drug regulators have missed the deadline for making a key decision regarding a Covid-19 vaccine from Novavax, days after the Food and Drug Administration’s vaccine chief was pushed out.The ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $152.57, a high ...

Organizations that develop sophisticated approaches to IP risk management can protect their exit potential and create ...

H.C. Wainwright lowered the firm’s price target on BioNTech (BNTX) to $145 from $150 and keeps a Buy rating on the shares. The firm says ...

BioNTech SE (NASDAQ:BNTX – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the eighteen brokerages that are covering the company, MarketBeat.com reports. Three research ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Shares in Moderna, Vaxcyte, Novavax and BioNTech all fell Monday after Peter Marks, head of the FDA office that reviews ...

Vaccine stocks are down after the health agency's top immunization official announced the move Monday, citing Secretary ...

Truist Financial analyst Asthika Goonewardene maintained a Buy rating on BioNTech SE (BNTX – Research Report) today. The company’s shares ...